Springer acquires Obesity Surgery from FD-Communications

May 23, 2006

Springer, one of the world's leading scientific, technical and medical publishers, has acquired Obesity Surgery, the leading periodical in the field of bariatric surgery, from FD-Communications, Inc.

Obesity Surgery has a 2004 ISI Impact Factor of 3.726, and is ranked seventh among the 139 peer-reviewed titles listed in the field of surgery. The journal publishes a wide range of content, including original research, reviews, technical innovations, guidelines, medico-legal matters and case reports. Obesity Surgery is widely read by bariatric surgeons, general surgeons, plastic surgeons, psychologists/psychiatrists, internists including endocrinologists, diabetologists and nutritional scientists worldwide. Obesity Surgery is the official journal of the International Federation for the Surgery of Obesity.

Rüdiger Gebauer, President of Global Publishing at Springer, commented, "Obesity Surgery significantly enhances our portfolio of surgery journals. The purchase of this prestigious publication is a clear indication that Springer's strategy of acquiring high-quality content is solidly on track." He added, "Springer will provide the infrastructure needed not only to ensure readership expansion among clinicians worldwide, but also increased visibility through international library consortia. In addition, Springer will bring enhanced online features and state-of-the-art medical publishing expertise to the journal."

Mervyn Deitel, MD, Editor-in-Chief of Obesity Surgery, said, "We are delighted to have a publisher capable of preserving the journal's integrity and quality. Springer has the reach to increase awareness of Obesity Surgery within the global community of bariatric surgeons." He continued, "With obesity clearly on the rise, the need for high-quality bariatric surgery content will continue to spread across the globe." Dr. Deitel and Frances Deitel will continue in their respective roles as Editor-in-Chief and Director of Advertising Sales for the journal.

Springer will publish Obesity Surgery in both print and electronic formats to serve the needs of researchers and medical professionals around the world. For the remainder of 2006 readers can view the electronic version at IngentaConnect (http://www.ingentaconnect.com/content/fd/os).

Beginning January 2007, Obesity Surgery will be available via SpringerLink, Springer's online information platform and will include Online First, a feature whereby articles are published online before they appear in print. Also in 2007, Obesity Surgery will offer all authors, via the Springer Open Choice program, the option of publishing their articles using the open access model (www.springer.com/openchoice). Obesity Surgery will continue to be produced in high-quality print format on a monthly basis.
-end-
About Springer
Springer Science+Business Media (www.springer.com) is one of the world's leading suppliers of scientific and specialist literature. It is the second-largest publishing group in the science, technology, and medicine (STM) sector and the largest business-to-business publisher in the German-language area. The group owns 70 publishing houses, together publishing a total of 1,450 journals and more than 5,000 new books a year. The group operates in over 20 countries in Europe, the USA, and Asia, and has some 5,000 employees. In 2005, it generated annual sales EUR 838 million.

About FD-Communications
FD-Communications Inc. is based in Toronto, Canada. Mervyn Deitel, MD, is the founding editor of Obesity Surgery (www.obesitysurgery.com), which he has published since 1991. Dr. Deitel pioneered total parenteral nutrition in the late 1960s and, subsequently, bariatric surgery from 1972-1996. He was a founding member of both the American Society for Bariatric Surgery and the International Federation for the Surgery of Obesity. In addition to receiving various awards, Dr. Deitel also edited several textbooks, most recently "Update: Surgery for the Morbidly Obese Patient".

Springer

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.